Simplifying Global Compliance
Glenmark Pharmaceuticals Ltd. - Nov. 17, 2017
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing